-
Next challenge, make vaccines work against new variants: Adar Poonawalla
A lot of sacrifices were made to put the company's focus on Covishield
-
Indian students can travel to Australia as Covishield get approval down under
Australia had imposed very strict travel restrictions on people travelling in and out of the country
-
Anathema towards Covishield must go
To emerge out of this dark period, the world needs to become more inclusive
-
WTO inches forward in Covid vaccine patent waiver talks
WTO has struggled to move forward on the issue since all decisions at the global trade body must be reached by consensus of all 164 member states
-
Serum Institute seeks test licence from DCGI to manufacture Covid vaccine Sputnik V
Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories
-
Covid-19 vaccine: ICMR to examine effectiveness of Covishield and Covaxin
The cumulative vaccine doses administered in the country has crossed 20 crore so far
-
Two doses of Oxford-AstraZeneca vaccine are 85-90% effective, real-world study finds
New analysis for the first time estimates that two doses of the Oxford-AstraZeneca vaccine provide around 85 to 90% protection against covid-19.
-
We continue to scale up Covid-19 vaccine manufacturing and prioritise India: SII
The Serum Institute of India said it will start export of Covid-19 vaccine by year-end
-
Will raise monthly production of vaccines to 10 crore doses by August: Serum Institute
Bharat Biotech also submitted to the Centre their production plan for the next four months. It said it can ramp up production to 7.8 crore doses by Au
-
Money9 Edit | Covid-19 vaccination drive needs better planning
India needs to put in place better demand forecasting. Citizens are playing ‘fastest fingers first’ in finding slots for getting themselves and th
